The proteinase activated receptor-2 (PAR-2) mediates mitogenic responses in human vascular endothelial cells: Characterization and evidence for coupling to the thrombin receptor (TR)  by Mirza, Humayun et al.
384A ABSTRACYS-Poster JACC February 1996 
and after 6.5 ± 1 days of constant nH;og~¢edn therapy (nitroglycerin patch 
0.4 mg/hr x 24 hours/day). At each study, brechial artery clilator esponses 
to hyperemk: Mood flow (flow-mediated dilation, an endothelium-dependent 
response) and to 0.4 mg sublingual nltrnglycedn were measured. Doppler 
flow velocity was measured at baseline and follow-up to ensure a similar 
flow stimulus. Resting artedal dimensions, byperemic flow velocities, artedal 
pmnsum, and heart rate were similar at baseline and tcflow-up studies. At 
baseline, the brachial mtewy dilated 5 :l: 3% to hypemmic flow and 17 ± 
7% to suhfingual nitroglycerin. After 6.5.4- 1 days of constant nifrnglycedn 
therapy, these responses were dramatically impaired. Breohlal artery dila- 
tion to hyperemic flow and sublingual niS"oglycedn was only 1 4- 2% (p = 
0.02 ve baseline) and 5 -;- 6% (p = 0.01 vs baseline), respectively. Thus, 
using a situate, rapid, noninvasive method to evaluate vascular adaptations 
to constant nitroglycerin therapy, we have demanstrated nltroglycodn toisr- 
ance and cross-tolerance. This method is a reliable and useful tool for the 
clinical detection of nifmglycedn tolerance. This technique should enhance 
our ability to investigate the mechanisms of nitroglycerin tolerance. 
~'~ Tmnsduction Mechanism in Signal 
Cardiovascular Tissues 
Wednesday, March 27, 1996, Noon--2:00 p.m. 
Orange County Convention Center, Hall E 
Presentation Hour: Noon-l:00 p.m. 
~ 17/~l-Estradiol Inhibits o f  Cultured Apoptosle 
Endothelial (;ells 
Sanfurd J. Gips, Rane J. Alvarez Jr., Emily E. Millikan, Chi Van Dang, 
Pascal J. Goldschmtdt-Clermont. Johns Hopkins University, Baltimore, MD 
Endothelial cell dysfunction and accelerated turnover are early steps in the 
athe~'.,gsnic process. Estrogen metabciltas are among the mast potent anti- 
alhsrngenic agents available fur post-manopaucal women although the com- 
plete mechanism of estrogen's protective ffect is unknown. We show that 
17b-astredldi (F.2) inhibits apoptoals in cultured endothelial cells and that 
the alfent may be mediated by increased tymsins phnspholylaflon (YP) of 
pp125 focal adhesion kJnasa (FAK). Bovine aorflo endothelial cells (BAEC) 
cultured __<. 2 passages and grown in E2-froe or 10 nM E2-containing me- 
dia were subjected to FACS analysis of in site terminal deoxynudeotidyl 
transferese.mediated dUTP nick end labeling (TUNEL assay) to quantitste 
apoptoals. E2 resulted in a 609,o reduction in apoptosis (n = 3, p = 0.02). 
We studied the effect of bdef (1 hr) exposure to valying concentrations of 
E2 -~ 1 mM E2-receptor antagonist ICI 164,384 (ICI) on YP of FAK. After 
normalizing for protein content, FAK was quantiteted on Western blots of 
immune complexes precipitated with anti-YP agarose beads, developed with 
anti-FAK and analyzed by densflomeW (n = 3): 
E2 conc. (M) 0 10 -5 10 -6 10 -7 10 -9 10 -5 ÷ ICI 10 -9 + ICI 
ReL density 1.00 2.38 2.60 3.99 3.22 2.25 1.as 
Compared to controls, I hr E2 exposure resulted in marked increase in YP 
of FAK at all E2 concentrations but was most pronounced in the p~,siologlcat 
(10-7-10 -9 M) range. 48 hr. pre-treatment with ICI partially inhibited the 
response. 
The independent observation that disruption of ceti-mstdx contact in- 
creases endothelial celt susceptibility to apoptosis supports the hypothesis 
that E2-1nduced hyperphosphorylation f FAK may reduce apoptosls by an- 
hanoing BAEC-substmtum Interaction. Inhibition of apeptoals by estrogens 
may account for some of the anti-sther~,~entc properties of these compounds. 
~ Atrial Natrluretic Peptlde induces Apoptosls In 
Neonatal Rst Cardiac Myocytes 
Can-Fang Wu 1 , Nanetto H. Bishopric 2, Richard E. Pratt I . ~ Stanford 
Un[vers#y School of Medicine, Stanford, CA; s Sill International, Menlo 
Park, CA 
Apoptoals of cardiac myocytas has been hypothesized to contribute to the 
pathogenasts of congestive heart failure (CHF), he;vevar, the identity of po- 
tential mediators of this apoptosls have not been dst~trmined. Inchronio CHF, 
plasma concentrations of atrial satdumtio poptlde (~,NP) are significantly in- 
creased, and ANP gane expression is upregulsted. However, Iltt!e is known 
about the direct effects of ANP on cardiac myocytes. In cultured neonatal rat 
cardiac myecytas, we found that ANP induced apoptosis in adose-dependent 
manner, as measured by both nuclear condensation and fragmentation as 
well as intranucieosomat DNA cleavage. Maximum effects occurred under 
serum-free conditions at 10 -e M ANP, with a 2.5 ± 0A9-foid (mean :t: SEM, 
n = 7) Increase over control In the percentage of apeptoflo coils, reaching 
apoptotic indices of 153 :t: 3.4% (n = 7). in contrast, the apoptstic index 
in ANP-treated, selectively plated, non-myocytas reached only 1.1 4- 0.2% 
(n = 4), suggesting that ANP-Inducod apoptosis was myscyto-speclfis. This 
specificity was confirmed by immunostalning using an anti-dasmtn antibody. 
RT-PCR indicated that all three ANP receptor subtypes were expressed in 
cultured myocytas. Sodium nifroprusside, which increases cyclic GMP via 
the release of NO and the subsequent activation of soluble gcanylyl cyclase, 
doce-dupandently induced apoptosis. Also, the cGMP-spocitlc phasphodi- 
esterase inhibitor, zapfinast, enhanced ANP-induced apoptosis at low con- 
centrations of ANP. Nompinsphdne, a growth factor for cardiac myscytes in 
this model, did not induce apoptosls. These results suggest hat ANP induces 
apoptosis via a cardiac n~ocyta-spe~flo, receptor-mediated pathway, pos- 
sibly involving the elevation of intracollular cGMP. ANP-mediated apoptoals 
of cardiac myocytes may play a significant role in the progression of chronic 
heart failure. 
~ T h e  Protelnase Activated Receptor-2 (PAR-2) 
Mediates Mltogenl© Responses In Human 
Vascular Endcthellal Cells: Charsctsrizctlon and 
Evidence for  Coupl ing to  the Thrombln Receptor 
(TR) 
Humayun Mk'za, Victoda Yatsula, Wedle F. Bahou. Dept. of Medicine, State 
Universirl of New York at Stony Brook, NY 
Pmteolytically cleaved receptors represent a novel class of receptors which 
mediate signaling by functional coupling to G proteins. Noribem analysis 
completed with an ~-900 bp mudne PAR-2 PCR fragment as probe demon- 
alratsd the ~.3.5 Kb PAR-2 transcript in total cellular RNA from HUVEC, al- 
though a second ~2 Kb transcript was evident using low stdngancy wash con- 
ditions. MicrospectrofluodmeW using fura2-10eded HUVEC demonstrated a
dose-dependent elevation in intmcytosolic calcium transients ([Ca+2]~) to 
mudne PA~ ($LIGRL), with an ~:~ ECso of 30/~M, and evidence for ho- 
malogous desensitization with full recovery at 45 minutes. Xenopus oocytos 
micruinjected with TR cRNA failed to respond to 200/~M PAR ss-~, and TR- 
targeted antisensa oligonudectidas pocifisafly abrogated thmmbin-inducod 
but not PAR~J-'44-medisted [Ca+2]l, excluding the possibility that TR/PAR-2 
cell-surface co-expression were structurally linked. To define potential func- 
tions for this receptor, endothelial cell proliferative responses to PAR -~'~ 
were studied, and demonstrated a dose- and time.dependent response sim- 
ilar to that seen with thmmbin or TR 4P~7 (thrombin receptor activating 
paptide, SFLLRN). Preectivation of HUVEC with either PAR 3s-e'4 or throm- 
bin resulted in heterologous desensitization to the corresponding agonist, 
an effect that was mediated pdmadly by TR internalization as evaluated by 
immunofluorescance and quantitative EUSA. These results ascribe a navel 
function to the PAR-2 receptor, imply that an enzyme agonist may circulate 
in plasma, and suggest he presence of an additional regulatory mechanism 
controlling receptor activation events in endothelial cells. 
